Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Rubicon Research Business Update

Rubicon Research reported the conclusion of a US FDA inspection at its Satara facility. The audit yielded one procedural observation unrelated to data integrity.

Source

BSE filing, NSE: RUBICON. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Rubicon Research Ltd: key numbers

Share price
₹1,564.00
Market cap
₹25,889 Cr
Revenue (annual)
₹1,754 Cr
Net profit (annual)
₹246.7 Cr
P/E (TTM)
89.8×Sector 46.1×
Promoter holding
51.25%-8.51% QoQ
FII holding
9.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Rubicon Research Ltd

All →

Other business update announcements

All →